Let’s explore more of the upcoming Summerville Book Festival on Feb. 15, this time focusing on the panels between the opening ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared to its daily average volume of about 5.67 million. All thanks to three ...

CHICAGO, February 13, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a new ...

Investors with a lot of money to spend have taken a bullish stance on Tempus AI TEM. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...

In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other health information services stocks. Health Information Services stocks have become a key ...

Tempus AI recently completed the acquisition of Ambry Genetics. The transaction enables it to expand into other areas of healthcare. Management projects strong year-over-year revenue growth for ...

In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other large-cap stocks. We previously covered 10 Large-Cap Stocks Insiders Are Buying Recently.

Stability shoes aren’t like they used to be. Take the Saucony Tempus 2, for instance, which incorporates subtle guiding tech—a supportive frame and asymmetrical design for medial support.

Tempus AI, Inc. is projected to achieve 30% YoY top line growth in Q4 2024 as presented in management's preliminary results. Growth is forecast to continue in the 23-25% range in eFY25. Tempus is ...

Tempus AI connects with over 2,500 institutions to collect real-time clinical data on millions of cancer patients. The company is able to use AI to derive diagnostic testing from this testing. The ...